Mycobacterial membrane transport and energy metabolism

Mycobacterial membrane transport and energy metabolism refers to the integrated systems of proteins and pathways that manage the movement of molecules across the mycobacterial cell envelope and the production of cellular energy (Cook et al., 2017). This target category is central to the survival of Mycobacterium tuberculosis (Mtb), particularly in its ability to persist in low-oxygen and nutrient-limited environments within host macrophages (Cook et al., 2017). Key components include the oxidative phosphorylation machinery, such as ATP synthase and the cytochrome bc1-aa3 complex, as well as essential transporters like MmpL3, which is involved in cell wall biosynthesis (Tahlan et al., 2012; Cook et al., 2017). These systems are vital for maintaining the proton motive force (PMF), generating ATP, and transporting essential cell wall components or extruding toxic substances (Zhang et al., 2003). Drugs targeting these processes, such as bedaquiline (an ATP synthase inhibitor) and telacebec (a QcrB inhibitor), have revolutionized the treatment of multidrug-resistant tuberculosis by effectively killing both actively replicating and dormant bacilli (Andries et al., 2005; Pethe et al., 2013). Targeting these pathways is particularly effective because Mtb relies heavily on oxidative phosphorylation for energy, especially in the nutrient-poor environment of the host macrophage (Cook et al., 2017). However, this term represents a broad functional category rather than a single molecular target, encompassing multiple distinct enzymes and transporters. Disruption of these systems often leads to a rapid decline in cellular ATP levels and loss of membrane integrity, resulting in bacterial death (Zhang et al., 2003). Safety concerns for drugs in this class include potential cross-reactivity with human mitochondrial components, although many modern agents show high selectivity for mycobacterial proteins (Andries et al., 2005). Overall, these pathways remain a primary focus for the development of next-generation anti-tubercular therapies.

Other names

Mycobacterial bioenergeticsMycobacterial oxidative phosphorylationMycobacterial respiratory chainMycobacterial efflux systemsMycobacterial membrane energetics

Inhibition of ATP synthesis, disruption of the electron transport chain, inhibition of membrane-bound transporters (e.g., MmpL3), and dissipation of the proton motive force.